A recent survey conducted by The Ohio State University Wexner Medical Center reveals hesitancy among Americans regarding vaccines for the fall of 2024. The survey, which included over 1,000 adults in the United States, found that 37% have received vaccines in the past but do not plan to do so this year. Another 37% stated they do not need flu, COVID-19, RSV, or pneumococcal vaccines.
The poll also showed that 56% have either received or plan to receive a flu shot this fall, while 43% have gotten or intend to get the latest COVID-19 vaccine. Notably, adults aged 65 and older were identified as the most likely group to receive CDC-recommended vaccines.
Nora Colburn, MD, medical director of Clinical Epidemiology at The Ohio State University Wexner Medical Center’s Richard M. Ross Heart Hospital, urged individuals to follow CDC recommendations if eligible. "We’re at the start of respiratory virus seasons when you have the triple threat of flu, COVID-19 and RSV. Unfortunately, there is a lot of misinformation about vaccinations, but the reality is that they are safe and highly effective in preventing serious illness and death," she said.
Dr. Colburn emphasized that older adults, people with chronic medical conditions, and pregnant individuals are most at risk during respiratory virus season.
The CDC advises everyone aged six months and older to receive an influenza vaccine annually. The latest COVID-19 vaccine is also recommended for this age group. RSV poses significant risks to young children, older adults, immunocompromised individuals, and those with chronic health issues like lung or heart diseases. The RSV vaccine is advised for anyone aged 75 and older; people between ages 60-74 at increased risk; and pregnant women between weeks 32-36 from September to January.
Pneumococcal vaccination is suggested for those under five years old and over 64 years old or anyone at higher risk of severe disease.
SSRS carried out this survey on behalf of Ohio State Wexner Medical Center through its national Opinion Panel Omnibus platform. Conducted from August 16 to August 18, 2024, it involved online and phone responses from 1,006 participants in English.
